Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced the acceptance of five PROVENGE® (sipuleucel-T) scientific abstracts and one...

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces a poster presentation on...

Design Disruptors marks the first time design leaders from Airbnb, Google Ventures, Pinterest, Dropbox, Facebook, Zendesk, Netflix, Spotify and more discuss how they build the products shaping the...

Resolution Bioscience today announced that its Resolution ctDx™ blood-based NGS platform was used to detect ALK fusions, ALK resistance mutations and other driver mutations in patients'...

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its leadership team will be making...